Articulo científico de dermatología sobre Trasplante cardíaco y su relación con el cáncer de piel de tipo melanoma y no melanoma pdf

Volumen 22, Numero 4 Octubre-Diciembre 2014

PDF del Número
ISSUU

índice del Número

Resumen

PDF del artículo

Referencias

Imágenes

Volver al índice

Otros artículos del Número

^-A A ⁺A

Artículo de revisión

Rev Asoc Colomb Dermatol. 2014; 22: 4 (Octubre-Diciembre), 293-300

Trasplante cardíaco y su relación con el cáncer de piel de tipo melanoma y no melanoma

Heart transplantation and its relationship to the type melanoma skin cancer and melanoma

Autor(es):

Claudia Marcela Gaviria

claugavi02@hotmail.com

Médica; residente de Dermatología, Universidad CES, Medellín, Colombia

Ana Paula Giraldo

Médica; residente de Dermatología, Universidad CES, Medellín, Colombia

Sol Beatriz Jiménez

Médica dermatóloga; jefe, Servicio de Dermatología, Universidad CES, Medellín, Colombia

Resumen:

El trasplante cardíaco es una cirugía que cada vez se hace con mayor frecuencia en nuestro medio. En la Clínica Cardio VID de Medellín aumenta cada año el número de pacientes a quienes se les practica este procedimiento. Ellos son candidatos al desarrollo de tumores de piel por su estado de inmunosupresión crónica, el cual aumenta si existen condiciones previas. La mayoría son pacientes mayores de 50 años de edad que han vivido en el trópico con poca fotoprotección y está demostrado que el carcinoma escamocelular es más frecuente en ellos. La intervención dermatológica temprana es uno de los factores de mayor impacto que se ha documentado en múltiples estudios y, a pesar de ello y de tener en cuenta que es uno de los principales tipos de cáncer junto con el linfoma, existe poca atención a la piel de estos pacientes.

Palabras clave:

cáncer de piel, trasplante de corazón, inmunosupresión.

Summary:

Heart transplantation is a surgery that is becoming more frequent in our environment. At the Clínica Cardio VID of Medellín the number of patients undergoing this procedure increases every year, and they become candidates for the development of skin tumors given their state of chronic immune suppression, which increases if there are preconditions. Most patients are older than 50 years of age who have lived in the tropics with little photoprotection and evidence that squamous cell carcinoma is more common in these patients. The early dermatological intervention is one of the factors with the greatest impact has been documented in multiple studies and despite this and consider it one of the main types of cancer along with lymphoma, is very little intervention in this area.

Key words:

skin cancer, heart transplantation, immunosuppression.

PDF del articulo

PDF del artículo

Referencias

Beltrán J, Franco C, Echeverría L, Gómez EA, Fernández D, Gómez JE, et al. Guías colombianas de cardiología. Trasplante cardiaco. Rev Colomb Cardiol. 2009;16:29-69.
Mendoza F. Aspectos ético-legales del trasplante de corazón. Rev Colomb Cardiol. 2007;14:259-75.
Naldi L, Fortina AB, Lovati S, Barba A, Gotti E, Tessari G, et al. Risk of melanoma skin cancer in Italian organ transplant recipients. A registry-based study. Transplantation. 2000;70:1479-84.
Krynitz B, Edgren G, Lindelöf B, Baecklund E, Brattström C, Wilczek H, et al. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008 –a Swedish population-based study. Int J Cancer. 2013;132:1429-38.
Wu J, Orengo I. Squamous cell carcinoma in solid-organ trasplantation. Dermatol Online J. 2002;8:4.
Ubilla M, Mastrobuoni S, Martín A, Cordero A, Alegría E, Gaviria J, et al. Heart transplant. Ann Sist Sanit Navar. 2006;29:63-78.
Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med. 2003;348:1681-91.
Chen PL, Chang HH, Chen IM, Lais ST, Shin CC, Weng ZC, et al. Malignancy after heart transplantation. J Chin Med Assoc. 2009;72:588-93.
Harwood CA, Mesher D, McGregor JM, Mitchell L, Leedham-Green M, Raftery M, et al. A surveillance model for skin cancer in organ transplant recipients: A 22-year prospective study in an ethnically diverse population. Am J Transpl. 2013;13:119-29.
Molina BD, Leiro Mg, Pulpón LA, Mirabet S, Yañez JF, Bonet LA et al. Incidence and risk factors for nonmelanoma skin cancer after heart transplantation. Transpl Proc. 2010;42:3001-5.
Geusau A, Dunkler D, Messeritsch E, Sandor N, Heidler G, Rodler S, et al. Non melanoma skin cancer and its risk factors in Austrian population of heart transplant recipients receiving induction therapy. Int J Dermatol. 2008;47:918-25.
Liu AS, Eriksson E. Four hundred seventeen squeamous cell cancers in a heart transplant patient. Ann Plast Surg. 2011;67:545-6.
Alter M, Satzger I, Schrem H, Kaltenborn A, Kapp A, Gutzmer R. Non-melanoma skin cancer is reduced after switch of immunosuppression to mTOR-inhibitors in organ transplant recipients. J Dtsch Dermatol Ges. 2014;12:480-8.
Yagdi T, Sharples L, Tsui S, Large PJ. Malignancy after heart transplantation: Analysis of 24-year experience at a single center. J Card Surg. 2009;24:572-9.
Ulrich C, Jurgensen JS, Degen A, Hackethal M, Ulrich M, Patel MJ, et al. Prevention of non-melanoma skin cancer in organ transplant recipients by regular use of a sunscreen: A 24 months, prospective, case-control study. Br J Dermatol. 2009;161:78-84.
Tessari G, Girolomoni G. Nonmelanoma skin cancer in solid organ transplant recipients: Update on epidemiology, risk factors and management. Dermatol Surg. 2012;38:1622-30.
Ali FR, Lear JT. Melanoma in organ transplant recipients: Incidence, outcomes and management considerations. J Skin Cancer. 2012;2012:1-5.
Engels EA, Pfeiffer RM, Fraumeni JR Jr, Kasiske BL, Israni AK, Snyder JJ, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA. 2011;306:1891-901.
Brewer JD, Christenson LJ, Weaver AL, Dapprich DC, Weenig RH, Lim KK, et al. Malignant melanoma in solid transplant recipients: Collection of database casesand comparison with surveillance, epidemiology and end results data for outcome analysis. Arch Dermatol. 2011;147:790-6.
A.K. Abbas, A.K. Lichtman, E.S. Pillai. Inmunología Celular y Molecular. 7ª edición, Elsevier Saunders. 2012.
Caforio AL, Fortina AB, Piaserico S, Alaibac M, Tona F, Feltrin G, et al. Skin cancer in heart transplant recipients: Risk factor analysis and relevance of immunosuppressive therapy. Circulation. 2000;102(Suppl.3):III222-7.
Goldsmith L, Katz S, Gilchrest B, Paller A, Leffell D, Wolff K. Fitzpatrick's Dermatology in General Medicine. 2 vols. 8a ed. United States of America: McGraw Hill Professional; 2012:1239 - 1259.
Harrison TR, Petersdorf RG, Resnick WR, Wilson JD, Wintrobe MM, Martin JB. Harrison's Principles of Internal Medicine. 2vols. 16a ed.United States of America: McGraw-Hill; 2005: 501 - 507.
Marco Legal: documentos técnicos y estadísticas. Fecha de consulta: 4 de junio de 2014. Disponible en: http://www.ins.gov.co/lineas-de-accion/Red-Nacional-Laboratorios/Paginas...
Firnhaber JM. Diagnosis and treatment of basal cell and squamous cell carcinoma. Am Fam Physician. 2012;86:161-8.
Wagner JA. Cancer after heart transplant: Implications for practice. Prog Transplant. 2012;22:374-8.
Rüegg CP, Graf N, Mühleisen B, Szucs TD, French LE, Surber C, et al. Squamous cell carcinoma of the skin induces considerable sustained cost of care in organ transplant recipients. J Am Acad Dermatol. 2012;67:1242-9.
Rinaldi M, Pellegrini C, D´Armini AM, Aiello M, Negri M, Arbustini E, et al. Neoplastic disease after heart transplantation: Single center experience. Eur J Cardiothorac Surg. 2001;19:696-701.
Alam M, Brown RN, Silber DH, Mullen GM, Feldman DS, Oren RM, et al. Increased incidence and mortality associated with skin cancers after cardiac transplant. Am J Transpl. 2011;11:1488-97.
Crespo-Leiro MG, Alonso-Pulpon L, Vásquez JA, Almenar L, Arizón JM, Brossa V, et al. Malignancy after heart transplantation: Incidence, prognosis and risk factors. Am J Transpl. 2008;8:10319.
Fortina AB, Piaserico S, Caforio AL, Abeni D, Alaibac M, Angelini A, et al.Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. Arch Dermatol. 2004;140:1079-85.
Jensen P, Hansen S, Moller B, Leivestad T, Pfeffer P, Geiran O, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive. J Am Acad Dermatol. 1999;40:177-86.
Salim A, Reece SM, Smith AG, Harrison D, Ramsay HM, Harden PN, et al. Sebaceous hyperplasia and skin cancer in patients undergoing renal transplant. J Am Acad Dermatol. 2006;55:878-81.
Mihalis EL, Wysong A, Boscardin WJ, Tang JY, Chren MM, Arron ST. Affecting sunscreen use and sun avoidance in a U.S. national sample of organ transplant recipients. Br J Dermatol. 2013;168:346-53.
Dal Sasso Mendes K, Murad F, Da Costa L, Prado K, Fontao M, Ohler L, et al. Photoeducation and photoprotection among liver transplant candidates. Gastroenterol Nurs. 2013;36:215-21.
Falk M, Magnusson H. Sun protection advice mediated by the general practitioner: An effective way to achieve long-term change of behaviour and attitudes related to sun exposure. Scand J Prim Heal Care. 2011;29:135-43.
Bandi P, Cokkinides VE, Weinstock MA, Ward EM. Physician sun protection counseling: Prevalence, correlates, and association with sun protection practices among US adolescents and their parents, 2004. Prev Med. 2010;51:172-7.
Feuerstein I, Geller A. Skin cancer education in transplant recipients. Prog Transpl. 2008;18:232-41.
Rueda X, Acosta A, Aristizábal FE. Guías de práctica clínica para el tratamiento del carcinoma basocelular. Rev Asoc Colom Dermatol. 2008;16:102-17.
Acosta A, Rueda X, Alba PL. Guías de práctica clínica para el tratamiento del carcinoma escamocelular. Rev Asoc Colomb Dermatol. 2008;16:116-34.
Tejaswi M, Levender M, O´Neil J, West C, Pearce D, Feldman S. Incidence, risk factors, and preventive management of skin cancers in organ transplant recipients: A review of single and multicenter retrospective studies from 2006 to 2010. Dermatol Surg. 2013; 39:345-364.
Liehn M, Fenske N, Glass F. Non-melanoma skin cancer in high-risk organ transplant recipients. Seminars in Oncology. 2012;39:134-8.